Concepedia

Circulating YKL-40 in patients with essential thrombocythemia and polycythemia vera treated with the novel histone deacetylase inhibitor vorinostat

Christen Lykkegaard Andersen, Mads Emil Bjørn, Mary Frances McMullin, Claire Harrison, Jan Samuelsson, Elisabeth Ejerblad, Sonja Zweegman, Savio Fernandes, D. Bareford, Steven Knapper,

Leukemia Research · 2014 · 13 citations · 34 references

DOI

Concepts

References

34

The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin

Lisa M. Butler, Xianbo Zhou, Weisheng Xu et al. · Proceedings of the National Academy of Sciences · 2002 · 508 citations · Full text

, , +12

Gene expression in papillary thyroid carcinoma reveals highly consistent profiles

Ying Huang, Manju L. Prasad, William J. Lemon et al. · Proceedings of the National Academy of Sciences · 2001 · 448 citations · Full text

, , +17

Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling

Christophe Deroanne, Karine Bonjean, S. Servotte et al. · Oncogene · 2002 · 412 citations

, , +14

Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer.

Julia S. Johansen · PubMed · 2006 · 408 citations

, , +11

Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors

Charlotte Bradbury, Farhat L. Khanim, Rachel Hayden et al. · Leukemia · 2005 · 401 citations

, , +13